Gemini Explorations, Inc. Reports Potential for Economic Recovery of Copper and Lead From New Ore Zone at La Tapata Gold Mine

CALGARY, AB–(EMWNews – August 22, 2008) – Gemini Explorations, Inc. (“Gemini”) (OTCBB: GXPI) is pleased to announce that sample results from a newly tested

mineralization zone located at its La Tapata Gold Mine site, show

indisputable evidence of an economically viable recovery of copper and lead

through the use of Diazem Corporation’s proprietary separation and capture

process. As previously reported, this process allows for the capture of a

uniquely high percentage of precious metals and certain base metals. This

process will provide for an overall increase in profitability over other

methods from ore with varying degrees of mineral concentrations. In a

recent report of sample results from La Tapata, Gemini noted that the

Diazem process enabled the recovery of a very economic 9.38 g/tonne Au

(gold) and an impressive 958.8 g/tonne Ag (silver) from the ore zone

tested.

Gemini now wishes to further report the potential of the Diazem process to

enhance the value of each tonne of processed ore through its tested ability

to recover economically relevant quantities of copper and lead from the

samples of the ore in the La Tapata test zone. The Diazem process recovered

impressive averages of 5.8% copper and 52.5% lead from the ore samples

tested. The capability to capture this quantity of metals, in addition to

the gold and silver recovered, translates to a significant increase in the

total value of the ore in question, hence producing a significant boost to

Gemini’s bottom-line profit for each tonne of ore mined.

In general, the Diazem process is more efficient and effective than

traditional hydrometallurgy techniques, which utilize cyanide leaching or

acid treatment. In fact, in a test performed by Diazem on an unidentified

ore sample, their process outperformed acid and cyanide treatments by

significant margins with regard to the capture of copper and lead.

Following are the results expressed in parts-per-million:

                        Copper                  Lead

Cyanide Treatment         6.5                  < 0.05



Acid Treatment          < 0.01                 < 0.05



Alternative               8.0                   12.8

Treatment

Michael Hill, CEO of Gemini, commented on this new approach to maximizing

ore value as follows, “The ability of the Diazem process to enable the

profitable recovery of copper and lead from the ore at La Tapata will add a

new, positive dimension to Gemini’s financial picture. We are looking

forward to completing the build out of La Tapata’s processing plant and

putting this project into full production.”

More information about Diazem is available on their company website at:

www.diazem.com/mining.html.

Notice Regarding Forward-Looking Statements

This news release contains “forward-looking statements,” as that term is

defined in Section 27A of the United States Securities Act of 1933 and

Section 21E of the Securities Exchange Act of 1934. Statements in this

press release which are not purely historical are forward-looking

statements and include any statements regarding beliefs, plans,

expectations or intentions regarding the future. Such forward-looking

statements include, among other things, the expectation that additional

financing will close on specified dates, the expected completion date of

the redevelopment of the La Tapata Gold and La Planada gold projects.

Actual results could differ from those projected in any forward-looking

statements due to numerous factors. Such factors include, among others, the

inherent uncertainties associated with mineral exploration, the ability of

Diazem Corporation to provide a cost-effective, environmentally friendly

method for capturing a uniquely high percentage of precious metals and

other economic minerals from the containing ore body. These

forward-looking statements are made as of the date of this news release,

and we assume no obligation to update the forward-looking statements, or to

update the reasons why actual results could differ from those projected in

the

forward-looking statements. Although we believe that the beliefs, plans,

expectations and intentions contained in this press release are reasonable,

there can be no assurance that such beliefs, plans, expectations or

intentions will prove to be accurate. Investors should consult all of the

information set forth herein and should also refer to the risk factors

disclosure outlined in our annual report on Form 10-KSB for the 2007 fiscal

year, our quarterly reports on Form 10-QSB and other periodic reports filed

from time-to-time with the Securities and Exchange Commission.